Compounds > valsartan
Page last updated: 2024-08-24

valsartan and Becker Muscular Dystrophy

valsartan has been researched along with Becker Muscular Dystrophy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Crea, F; Lamendola, P; Lanza, GA; Leone, D; Lombardo, A; Melita, V; Mercuri, EM; Palermo, C; Pane, M; Pennestrì, F; Villano, A1
Gallinoro, E; Golino, P; Palladino, A; Papa, AA1

Other Studies

2 other study(ies) available for valsartan and Becker Muscular Dystrophy

ArticleYear
Duchenne muscular dystrophy: preliminary experience with sacubitril-valsartan in patients with asymptomatic left ventricular dysfunction.
    European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:17

    Topics: Adult; Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Drug Combinations; Echocardiography; Humans; Maximum Tolerated Dose; Muscular Dystrophy, Duchenne; Valsartan; Ventricular Dysfunction, Left; Young Adult

2020
Beneficial effects of one-month sacubitril/valsartan treatment in a patient affected by end-stage dystrophinopathic cardiomyopathy.
    Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology, 2020, Volume: 39, Issue:3

    Topics: Activities of Daily Living; Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Cardiomyopathy, Dilated; Drug Combinations; Drug Monitoring; Dystrophin; Echocardiography; Exercise Tolerance; Heart Failure; Humans; Male; Middle Aged; Muscular Dystrophy, Duchenne; Stroke Volume; Symptom Assessment; Treatment Outcome; Valsartan

2020